Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Cuts Reps Before Lipitor Patent Expires
Pharmalot
Monday, August 15, 2011 - 10:33am
tags:
layoffs, drug reps, Pfizer, patents, Lipitor
When to Buy Biotechnology Stocks?
Seeking Alpha
Monday, August 15, 2011 - 10:30am
tags:
Alexion, Arena Pharmaceuticals, Dendreon, Human Genome Sciences, MannKind, Orexigen
GlaxoSmithKline: Second PhIII Parkinson's drug study turns in winning data
Fierce Biotech
Monday, August 15, 2011 - 10:28am
tags:
GSK, Parkinson's Disease, IPX066, Impax
Warning: Vertex Pharmaceuticals May Be Hiding Weakness
Motley Fool
Monday, August 15, 2011 - 10:07am
tags:
Vertex Pharmaceuticals
Allos Therapeutics Evenly Poised
Yahoo/Zacks.com
Monday, August 15, 2011 - 10:06am
tags:
Allos, Amag Pharmaceuticals
Gilead Quad HIV Drug Meets Standard
TheStreet.com
Monday, August 15, 2011 - 10:05am
tags:
Gilead, HIV, Quad
Pfizer Wins Viagra Patent Case Against Teva
Bloomberg
Monday, August 15, 2011 - 9:46am
tags:
Pfizer, Viagra, patents, Teva Pharmaceuticals
Relatively Good Performance Detected in Shares of Optimer Pharmaceuticals in the Pharmaceuticals Industry
Financial News Network
Sunday, August 14, 2011 - 11:38am
tags:
Optimer, ViroPharma, Mylan, Medicines Company, AstraZeneca
MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile
Pharmabiz
Sunday, August 14, 2011 - 11:32am
tags:
MAP Pharmaceuticals, Levadex, migraines, Tempo inhaler
Investors Blocking Pfizer's Bid Say Icagen's Value Could Be $165 Million
Motley Fool
Sunday, August 14, 2011 - 11:28am
tags:
Pfizer, Icagen, M&A
The Next Big Thing in Biotech: Regeneron Pharmaceuticals (video)
The Street
Sunday, August 14, 2011 - 11:27am
tags:
Regeneron
Bydureon FDA Action Date Set for January 28, 2012
Pipeline Review
Saturday, August 13, 2011 - 4:20pm
tags:
Bydureon, Eli Lilly, Alkermes
Novo Nordisk: Profiting From the Company's Pharmaceutical Expertise
Seeking Alpha
Saturday, August 13, 2011 - 4:15pm
tags:
Novo Nordisk
Deutsche Bank Expects Pharmaceutical Sector To Outperform
iStockAnalyst
Saturday, August 13, 2011 - 4:13pm
tags:
analysis
Akebia Therapeutics Completes Series B
techfinance.ca
Saturday, August 13, 2011 - 4:11pm
tags:
Akebia Therapeutics
5 Tips for Spine Device and Pharmaceutical Companies in the ACO World
Becker's Orthopedic And Spine
Saturday, August 13, 2011 - 4:09pm
tags:
ACOs
ShangPharma plans $10 M share repurchase program
Bioscience Technology
Saturday, August 13, 2011 - 4:07pm
tags:
ShangPharma
Nymox Pharma Q2 Loss Widens - Quick Facts
RTT News
Saturday, August 13, 2011 - 3:50pm
tags:
Nymox, earnings
Mylan Laboratories has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg
Zacks
Saturday, August 13, 2011 - 3:47pm
tags:
Mylan, Uroxatral, benign prostatic hyperplasia, generics
What Happened to U.S. Pharma?
Motley Fool
Saturday, August 13, 2011 - 2:59pm
tags:
JNJ, Bristol-Myers Squibb, Eli Lilly, Merck, Vertex Pharmaceuticals, Pfizer, Mead Johnson

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.